Funding to the Pharmaceutical Technologies Group is derived from a wide variety of sources, from research council grants and DTI collaborative R&D programmes to industrial, commercial and venture capital funding. Grants include:

2008-2011 TSB Collaborative R&D programme. High Value Manufacturing Call. LyoSense. In situ dielectric monitoring of the freeze-drying process. Geoff Smith

2008-2011 The National Institute for Health Research (NHIR) - New and Emerging Applications of Technology (NEAT) Programme. Clinical development of InSMART delivery system. Joan Taylor

2008-2008 Prospect IP Venture Capital. InSMART development of commercially aimed prototypes. Joan Taylor

2008-2010 EPSRC First Grant. In-process particle sizing by refractive index measurement. Mingzhong Li

2007-2008 NHIR - New and Emerging Applications of Technology (NEAT) Feasibility Grant: Novel methods for paediatric drug monitoring using microanalysis. Sangeeta Tanna

2005-2008 DTI Collaborative R&D programme. Micro and Nanotechnologies (MNT). CellSense. A multinodal temperature sensor for distributed temperature sensing. Geoff Smith

2004-2006 The National Institute for Health Research (NHIR) - New and Emerging Applications of Technology (NEAT) Programme: The development of a totally implantable closed-loop insulin delivery device for the management of diabetes. Sangeeta Tanna

2006 EMDA/HEFCE, Innovation Fellowship. Geoff Smith

2005 EMDA/HEFCE, Innovation Fellowship. Geoff Smith

2004-2009 Lachesis Venture Capital Fund. Development of InSMART delivery system. Joan Taylor

2004 HEIF2, Medici Fellowship. Geoff Smith

2004 HEROBAC, Innovation Fellowship. Geoff Smith

2002 EPSRC, visiting scientist, Fluctuation Noise Spectroscopy. Geoff Smith

Recent industrial collaborators in Pharmaceutical Technologies Research include: AstraZeneca, Agilent Technologies, Mundipharma, Pfizer, Malvern Instruments, GEA Pharma Systems.